التفاصيل البيبلوغرافية
| العنوان: |
Uphill battle: Innovation of thiopurine therapy in global inflammatory bowel disease care. |
| المؤلفون: |
Bayoumy, Ahmed B., Mulder, Chris J. J., Ansari, Azhar R., Barclay, Murray L., Florin, Tim, Kiszka-Kanowitz, Marianne, Derijks, Luc, Sharma, Vishal, de Boer, Nanne K. H. |
| المصدر: |
Indian Journal of Gastroenterology; Feb2024, Vol. 43 Issue 1, p36-47, 12p |
| مستخلص: |
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract that encompasses two major conditions: Crohn's disease (CD) and ulcerative colitis (UC). Historically, IBD has been primarily reported in western countries, but over the past decades, its prevalence is rapidly increasing, especially in lower and middle-income countries (LMICs) such as India and China and also in Sub-Saharan Africa. The prevalence of IBD in LMICs has been the subject of growing concern due to the impact of access to public healthcare and the burden it places on healthcare resources. The classical thiopurines face significant challenges due to cessation of therapy in approximately half of patients within one year due to side effects or ineffectiveness. In this article, we highlight innovating thiopurine treatment for IBD patients in downregulating side effects and improving efficacy. [ABSTRACT FROM AUTHOR] |
|
Copyright of Indian Journal of Gastroenterology is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder